Keyphrases
Diabetic Mice
100%
Glucose Metabolism
100%
Orexin Receptors
100%
Orexin Antagonist
100%
Chronotherapeutics
100%
Glucose Intolerance
60%
Db Mouse
60%
Orexin
40%
Orexin 2 Receptor
40%
Locomotor Activity
20%
Wakefulness
20%
Sleep Patterns
20%
Liver
20%
Expression Level
20%
Receptor Antagonist
20%
White Adipose Tissue
20%
Disrupted Sleep
20%
Functional Links
20%
Food Intake
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Orexin System
20%
Inflammatory Factors
20%
Type 2 Diabetic
20%
Rapid Eye Movement Sleep
20%
Sleep Effects
20%
Type 2 Diabetes Risk
20%
Streptozotocin-induced
20%
Insomnia
20%
Central Action
20%
O2 Consumption
20%
Sleep Abnormalities
20%
CO2 Production
20%
Pharmacology, Toxicology and Pharmaceutical Science
Orexin Receptor Antagonist
100%
Orexin Antagonist
100%
Orexin
75%
Glucose Intolerance
75%
Db/Db Mouse
75%
Receptor Antagonist
50%
Orexin 2 Receptor
50%
Non Insulin Dependent Diabetes Mellitus
50%
Diabetes Mellitus
25%
Streptozotocin
25%
Orexin 1 Receptor
25%
Carbon Dioxide
25%